Skip to content

Clinical trials

Observational Breast Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Observational Country / region: United States Clear all

1,006 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200010
200114
200211
200323
200418
200534
200644
200751
200854
200960
201052
201139
201236
201337
201441
201541
201631
201744
201834
201944
202025
202142
202246
202341
202437
202540
202624

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed599
Recruiting127
Terminated89
Active, not recruiting68
Unknown status58
Withdrawn35
Not yet recruiting11
Suspended10
Enrolling by invitation9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center79
Mayo Clinic53
National Cancer Institute (NCI)53
M.D. Anderson Cancer Center48
UNC Lineberger Comprehensive Cancer Center25
Pfizer19
Abramson Cancer Center at Penn Medicine18
Stanford University18
Case Comprehensive Cancer Center16
Wake Forest University Health Sciences15

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms1,006
Lung Neoplasms84
Neoplasms73
Prostatic Neoplasms70
Ovarian Neoplasms60
Colorectal Neoplasms55
Colonic Neoplasms48
Melanoma37
Pancreatic Neoplasms31
Neoplasm Metastasis29

Trials

Showing 1 to 25 of 1,006. Each trial links to its page on Pharma Observatory.

906 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.